|
59
|
222
|
5fgiL |
Yeast 20s proteasome beta1-t1a beta2-t1a double mutant in complex with carfilzomib |
|
59
|
196
|
5fghN |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) in complex with mg132 |
|
61
|
195
|
5fhsJ |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) in complex with carfilzomib |
|
62
|
241
|
5fg9G |
Yeast 20s proteasome beta2-t(-2)v mutant |
|
57
|
226
|
5fgaH |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) |
|
67
|
233
|
5fghM |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) in complex with mg132 |
|
68
|
244
|
5fgdB |
Yeast 20s proteasome beta5-h(-2)l-t1a double mutant in complex with carfilzomib |
|
72
|
240
|
5fg9C |
Yeast 20s proteasome beta2-t(-2)v mutant |
|
69
|
250
|
5fhsA |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) in complex with carfilzomib |
|
64
|
231
|
5fg9E |
Yeast 20s proteasome beta2-t(-2)v mutant |
|
72
|
214
|
5fgfK |
Yeast 20s proteasome beta5-h(-2)a-t1a-k81r triple mutant in complex with carfilzomib |
|
43
|
231
|
5fmgF |
Structure and function based design of plasmodium-selective proteasome inhibitors |
|
70
|
212
|
5fg9K |
Yeast 20s proteasome beta2-t(-2)v mutant |
|
58
|
204
|
5fgaI |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) |
|
62
|
241
|
5fgiG |
Yeast 20s proteasome beta1-t1a beta2-t1a double mutant in complex with carfilzomib |
|
50
|
232
|
5fmgC |
Structure and function based design of plasmodium-selective proteasome inhibitors |
|
63
|
241
|
5fgaG |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) |
|
64
|
233
|
5fgdM |
Yeast 20s proteasome beta5-h(-2)l-t1a double mutant in complex with carfilzomib |
|
39
|
247
|
5fmgA |
Structure and function based design of plasmodium-selective proteasome inhibitors |
|
62
|
241
|
5fg7G |
Yeast 20s proteasome beta2-t1a mutant |
|
70
|
244
|
5fgaB |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) |
|
54
|
204
|
5fgiI |
Yeast 20s proteasome beta1-t1a beta2-t1a double mutant in complex with carfilzomib |
|
71
|
244
|
5fg7B |
Yeast 20s proteasome beta2-t1a mutant |
|
67
|
250
|
5fghA |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) in complex with mg132 |
|
71
|
244
|
5fgiB |
Yeast 20s proteasome beta1-t1a beta2-t1a double mutant in complex with carfilzomib |
|
40
|
194
|
5fmgK |
Structure and function based design of plasmodium-selective proteasome inhibitors |
|
58
|
222
|
5fgeH |
Yeast 20s proteasome beta5-h(-2)t-t1a double mutant in complex with carfilzomib |
|
68
|
244
|
5fgfB |
Yeast 20s proteasome beta5-h(-2)a-t1a-k81r triple mutant in complex with carfilzomib |
|
69
|
243
|
5fgeF |
Yeast 20s proteasome beta5-h(-2)t-t1a double mutant in complex with carfilzomib |
|
69
|
250
|
5fgfA |
Yeast 20s proteasome beta5-h(-2)a-t1a-k81r triple mutant in complex with carfilzomib |
|
57
|
204
|
5fg9I |
Yeast 20s proteasome beta2-t(-2)v mutant |
|
72
|
212
|
5fg7K |
Yeast 20s proteasome beta2-t1a mutant |
|
42
|
228
|
5fmgD |
Structure and function based design of plasmodium-selective proteasome inhibitors |
|
71
|
240
|
5fg7C |
Yeast 20s proteasome beta2-t1a mutant |
|
64
|
231
|
5fggE |
Yeast 20s proteasome beta5-l(-49s)_d17n double mutant in complex with carfilzomib |
|
69
|
250
|
5fggA |
Yeast 20s proteasome beta5-l(-49s)_d17n double mutant in complex with carfilzomib |
|
61
|
222
|
5fhsL |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) in complex with carfilzomib |
|
66
|
231
|
5fgfE |
Yeast 20s proteasome beta5-h(-2)a-t1a-k81r triple mutant in complex with carfilzomib |
|
65
|
231
|
5fgdE |
Yeast 20s proteasome beta5-h(-2)l-t1a double mutant in complex with carfilzomib |
|
68
|
244
|
5fhsB |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) in complex with carfilzomib |
|
74
|
240
|
5fgaC |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) |
|
58
|
222
|
5fhsH |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) in complex with carfilzomib |
|
63
|
241
|
5fghG |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) in complex with mg132 |
|
67
|
249
|
5fgiA |
Yeast 20s proteasome beta1-t1a beta2-t1a double mutant in complex with carfilzomib |
|
40
|
226
|
5fmgB |
Structure and function based design of plasmodium-selective proteasome inhibitors |
|
67
|
250
|
5fg9A |
Yeast 20s proteasome beta2-t(-2)v mutant |
|
71
|
243
|
5fhsF |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) in complex with carfilzomib |
|
43
|
230
|
5fmgE |
Structure and function based design of plasmodium-selective proteasome inhibitors |
|
69
|
243
|
5fg9F |
Yeast 20s proteasome beta2-t(-2)v mutant |
|
70
|
212
|
5fgaK |
Yeast 20s proteasome beta5-k33a mutant (propeptide expressed in trans) |
